Komen’s Position on Stem Cells Remains Unclear

<a href="http://www.flickr.com/photos/inthehandofdante/3929434629/sizes/z/in/photostream/">timbrauhn</a>/Flickr

Let our journalists help you make sense of the noise: Subscribe to the Mother Jones Daily newsletter and get a recap of news that matters.


Susan G. Komen for the Cure has hedged its decision to stop providing grants to Planned Parenthood for breast cancer screenings after that move kicked off a good deal of outrage. But it’s still not clear where the group stands on embryonic stem cell research, another subject that has made Komen a target of anti-abortion groups.

Anti-abortion groups have been pressuring Komen to stop providing millions in support to research institutions like Johns Hopkins University School of Medicine and the U.S. National Cancer Institute because those organizations also conduct research using embryonic stem cells.

As we reported yesterday, news outlets affiliated with the anti-abortion rights movement have been touting a recent press release from Komen that insists that it is not funding embryonic stem cell research and does not support any cancer research that involves “destroying a human embryo.”

A reader managed to find a copy of the Nov. 30 press release, which has since disappeared from Komen’s website. I’ve posted that document here, and it definitely seems to suggest that Komen now opposes embryonic stem cell research. That wasn’t the case a few years ago, when this Komen newsletter touted the potential benefits of using embryonic stem cells:

Embryonic stem cells (derived from embryos that develop from eggs that have been fertilized in vitro and then donated for research purposes) have the potential to give rise to many different types of tissue. Because of this, embryonic stem cells are currently considered to have the most potential for use in the regeneration of diseased or injured tissues. Another potential role is providing a better understanding of cancer development.

The National Cancer Institute notes that “embryonic stem cells hold far more potential than adult cells” when it comes to research, because embryonic cells “can change into more tissue types and replicate indefinitely, two properties not generally shown with adult cells.”

I’ve asked Komen to comment on whether they have formally changed their position on this type of research, but have not received a response. Although many are heralding Komen’s semi-cave on Planned Parenthood, the group’s current position is on stem cell research is still a mystery, and one that needs to be resolved—particularly since research on “a cure” is central to Komen’s mission.

DOES IT FEEL LIKE POLITICS IS AT A BREAKING POINT?

Headshot of Editor in Chief of Mother Jones, Clara Jeffery

It sure feels that way to me, and here at Mother Jones, we’ve been thinking a lot about what journalism needs to do differently, and how we can have the biggest impact.

We kept coming back to one word: corruption. Democracy and the rule of law being undermined by those with wealth and power for their own gain. So we're launching an ambitious Mother Jones Corruption Project to do deep, time-intensive reporting on systemic corruption, and asking the MoJo community to help crowdfund it.

We aim to hire, build a team, and give them the time and space needed to understand how we got here and how we might get out. We want to dig into the forces and decisions that have allowed massive conflicts of interest, influence peddling, and win-at-all-costs politics to flourish.

It's unlike anything we've done, and we have seed funding to get started, but we're looking to raise $500,000 from readers by July when we'll be making key budgeting decisions—and the more resources we have by then, the deeper we can dig. If our plan sounds good to you, please help kickstart it with a tax-deductible donation today.

Thanks for reading—whether or not you can pitch in today, or ever, I'm glad you're with us.

Signed by Clara Jeffery

Clara Jeffery, Editor-in-Chief

payment methods

We Recommend

Latest